| 2026-06-06 21:50 | UU:ELEK | | News Release200 | Millionaires, Billionaires, Microcap and Penny Stock Investors - This Is Your Time To Shine |
| 2026-06-06 21:25 | UU:ELEK | | News Release200 | Millionaires, Billionaires, Institutional, Microcap & Penny Stock Investors - Your Opportunity To Own a Stake in Elektros Inc.'s Lithium Mining, Rare Earth Minerals & EV Patent Technology at Today's Ground-Floor Value |
| 2026-06-06 21:15 | UU:ELEK | | News Release200 | Millionaires, Billionaires, Institutional Investors, Microcap Investors, Penny Stock Investors - This Is Your Time To Shine |
| 2026-06-06 21:05 | UU:ELEK | | News Release200 | Microcap, Penny Stock, and Institutional Investors Across the Globe Are Discovering a Unique Opportunity in Elektros Inc. |
| 2026-06-06 19:05 | UU:DUK | | News Release200 | Duke Energy offers tips to save energy and money as temperatures rise in the Carolinas |
| 2026-06-06 17:00 | UU:SENS | | News Release200 | Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems |
| 2026-06-06 16:45 | UU:CORT | | News Release200 | Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym(TM) |
| 2026-06-06 14:45 | UU:DXCM | | News Release200 | Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin |
| 2026-06-06 14:30 | UU:LLY | | News Release200 | Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications |
| 2026-06-06 09:52 | UU:AGAE | | News Release200 | All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration |
| 2026-06-06 09:00 | UU:PFE | | News Release200 | Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide |
| 2026-06-06 09:00 | UU:ABT | | News Release200 | New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis |
| 2026-06-06 07:00 | UU:PODD | | News Release200 | Insulet Reveals New Data Supporting Breakthrough Omnipod(TM) 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care |
| 2026-06-06 05:15 | UU:CGEM | | News Release200 | Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress |